- Home
- VRNA vs BAK Comparison
VRNA vs BAK Comparison
Compare VRNA & BAK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VRNA
- BAK
- Stock Information
- Founded
- VRNA 2005
- BAK 1972
- Country
- VRNA United Kingdom
- BAK Brazil
- Employees
- VRNA N/A
- BAK N/A
- Industry
- VRNA Biotechnology: Pharmaceutical Preparations
- BAK Major Chemicals
- Sector
- VRNA Health Care
- BAK Industrials
- Exchange
- VRNA Nasdaq
- BAK Nasdaq
- Market Cap
- VRNA 3.4B
- BAK 1.7B
- IPO Year
- VRNA 2017
- BAK N/A
- Fundamental
- Price
- VRNA $48.33
- BAK $4.04
- Analyst Decision
- VRNA Strong Buy
- BAK Strong Buy
- Analyst Count
- VRNA 6
- BAK 3
- Target Price
- VRNA $43.83
- BAK $9.75
- AVG Volume (30 Days)
- VRNA 854.0K
- BAK 1.2M
- Earning Date
- VRNA 02-27-2025
- BAK 11-06-2024
- Dividend Yield
- VRNA N/A
- BAK N/A
- EPS Growth
- VRNA N/A
- BAK N/A
- EPS
- VRNA N/A
- BAK N/A
- Revenue
- VRNA $5,624,000.00
- BAK $13,764,416,401.00
- Revenue This Year
- VRNA N/A
- BAK $14.26
- Revenue Next Year
- VRNA $644.06
- BAK $8.26
- P/E Ratio
- VRNA N/A
- BAK N/A
- Revenue Growth
- VRNA 1127.95
- BAK 2.86
- 52 Week Low
- VRNA $11.39
- BAK $3.70
- 52 Week High
- VRNA $47.29
- BAK $10.98
- Technical
- Relative Strength Index (RSI)
- VRNA 71.27
- BAK 31.23
- Support Level
- VRNA $45.05
- BAK $3.70
- Resistance Level
- VRNA $47.29
- BAK $3.92
- Average True Range (ATR)
- VRNA 2.21
- BAK 0.19
- MACD
- VRNA 0.45
- BAK 0.01
- Stochastic Oscillator
- VRNA 100.00
- BAK 17.12
About VRNA Verona Pharma plc
Verona Pharma PLC is a clinical-stage biopharmaceutical company focused on developing and commercializing therapeutics for the treatment of respiratory diseases with unmet medical needs. The company is currently focusing on developing its Ensifentrine product candidate, which will treat chronic obstructive pulmonary disease (COPD), cystic fibrosis (CF), and other respiratory diseases, including asthma.
About BAK Braskem SA ADR
Braskem SA manufactures and sells chemicals, petrochemicals, fuels, and utilities. The company's geographical segments include Brazil; the United States and Europe and Mexico. It derives a majority of its revenue from Brazil. It produces olefins, such as ethylene, polymer and chemical-grade propylene, butadiene, and butene-1; fuels, such as automotive gasoline, liquefied petroleum gas, or LPG, ethyl tertiary-butyl ether, or ETBE, and methyl tertiary-butyl ether, or MTBE; intermediates, such as cumene and others.